[go: up one dir, main page]

UY25811A1 - Derivados de pirrolidina que son antagonistas del receptor ccr-3 - Google Patents

Derivados de pirrolidina que son antagonistas del receptor ccr-3

Info

Publication number
UY25811A1
UY25811A1 UY25811A UY25811A UY25811A1 UY 25811 A1 UY25811 A1 UY 25811A1 UY 25811 A UY25811 A UY 25811A UY 25811 A UY25811 A UY 25811A UY 25811 A1 UY25811 A1 UY 25811A1
Authority
UY
Uruguay
Prior art keywords
alkyl
haloalkyl
heteroalkyl
acyl
alkylene
Prior art date
Application number
UY25811A
Other languages
English (en)
Inventor
John Patrick Williams
John Saunders
Daniel Harry Rogers
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of UY25811A1 publication Critical patent/UY25811A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Esta invención se refiere a determinados derivados de 3-aminometilpirrolidina de fórmula (1), en la que: Z es -N- o -(N+ER)-X-, en donde R es alquilo, haloalquilo, aralquilo, hidroxialquilo, carboxialquilo, alcoxicarbonilalquilo o cianoalquilo, y X- es un contraión farmacéuticamente aceptable; Ar1 y Ar2 son, independientemente uno de otro, arilo o heteroarilo; Q es un alquileno; R1 es H o alquilo; A es: I) -N(R2)C(O)- cuando B es: i) un alquileno, -NR5C(O)- y -N(R6)SO2; o ii) una cadena alquinileno; en la que: R2 es H, alquilo, acilo, haloalquilo, heteroalquilo; y R5 y R6 son, independientemente uno de otro, H, alquilo, acilo, haloalquilo, heteroalquilo; o II) un grupo seleccionado de -N(R2)C(S)-, -N(R2)C(O)N(R3), -N(R2)SO2-, -OC(O)N(R3)-, en el que B es: i) un enlace; ii) una cadena alquileno; iii) una cadena alquenileno; o iv) una cadena alquinileno; en la que: R3 es H, alquilo, acilo, haloalquilo, heteroalquilo; y profármacos, isómeros individuales y sales farmacéuticamente aceptables de los mismos. Asimismo, la invención se refiere a composiciones farmacéuticas que los contienen, a métodos para su uso y a métodos para la preparación de estos compuestos. Dichos compuestos son antagonistas del receptor CCR-3 y por tanto, son útiles en el tratamiento del asma. Ej. no limitante: N-[1-(2,3-diclorobencil)pirrolidin-3-(RS)-ilmetil]-2-[5-(4-metoxifenil)pirimidin-2-ilsulfanil]acetamida
UY25811A 1998-11-20 1999-11-19 Derivados de pirrolidina que son antagonistas del receptor ccr-3 UY25811A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10929798P 1998-11-20 1998-11-20

Publications (1)

Publication Number Publication Date
UY25811A1 true UY25811A1 (es) 2001-07-31

Family

ID=22326918

Family Applications (1)

Application Number Title Priority Date Filing Date
UY25811A UY25811A1 (es) 1998-11-20 1999-11-19 Derivados de pirrolidina que son antagonistas del receptor ccr-3

Country Status (27)

Country Link
US (1) US6166015A (es)
EP (1) EP1131288A1 (es)
JP (1) JP3593037B2 (es)
KR (1) KR20010086045A (es)
CN (1) CN1158256C (es)
AR (1) AR023707A1 (es)
AU (1) AU763960B2 (es)
BR (1) BR9915520A (es)
CA (1) CA2350903A1 (es)
CO (1) CO5140119A1 (es)
CZ (1) CZ20011760A3 (es)
DE (1) DE19955794A1 (es)
ES (1) ES2158814B1 (es)
FR (1) FR2786185A1 (es)
GB (1) GB2343893B (es)
HU (1) HUP0104364A2 (es)
ID (1) ID29067A (es)
IL (1) IL143226A0 (es)
IT (1) IT1307900B1 (es)
MA (1) MA26762A1 (es)
NO (1) NO20012411L (es)
PE (1) PE20001403A1 (es)
PL (1) PL348375A1 (es)
TR (1) TR200101398T2 (es)
UY (1) UY25811A1 (es)
WO (1) WO2000031032A1 (es)
ZA (1) ZA200103942B (es)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL125658A0 (en) 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
US6339087B1 (en) 1997-08-18 2002-01-15 Syntex (U.S.A.) Llc Cyclic amine derivatives-CCR-3 receptor antagonists
US6316623B1 (en) * 1998-08-21 2001-11-13 Isis Pharmaceuticals, Inc. Ethylenediamine compound libraries
EP1131290B1 (en) 1998-11-20 2008-02-20 F. Hoffmann-La Roche Ag Piperidine ccr-3 receptor antagonists
WO2000069432A1 (en) * 1999-05-18 2000-11-23 Teijin Limited Remedies or preventives for diseases in association with chemokines
KR100667645B1 (ko) * 1999-08-04 2007-02-28 데이진 가부시키가이샤 환상 아민 ｃｃｒ3 길항제
ES2276706T3 (es) * 1999-12-08 2007-07-01 Teijin Limited Antagonistas del receptor ccr5 de aminas ciclicas.
CA2423251A1 (en) 2000-09-29 2002-04-04 Glaxo Group Limited Morpholin-acetamide derivatives for the treatment of inflammatory diseases
NZ525055A (en) * 2000-09-29 2004-09-24 Glaxo Group Ltd Compounds useful in the treatment of inflammatory diseases
AU2002216107A1 (en) * 2000-12-19 2002-07-01 F. Hoffmann-La Roche Ag Substituted pyrrolidines as CCR-3 receptor antagonists
FR2821356A1 (fr) * 2001-02-23 2002-08-30 Cerep Nouveaux derives d'arylcarbamates et d'arylurees, preparations et utilisations
GB0117387D0 (en) * 2001-07-17 2001-09-05 Novartis Ag Organic compounds
BR0212451A (pt) * 2001-09-13 2004-10-19 Hoffmann La Roche Antagonistas de receptores de ccr-3 v
US7067549B2 (en) * 2001-12-31 2006-06-27 Actelion Pharmaceuticals Ag Pyrrolidone carboxamides
GB0207443D0 (en) * 2002-03-28 2002-05-08 Glaxo Group Ltd Novel compounds
GB0207432D0 (en) * 2002-03-28 2002-05-08 Glaxo Group Ltd Novel compounds
GB0207436D0 (en) * 2002-03-28 2002-05-08 Glaxo Group Ltd Novel compounds
GB0207439D0 (en) * 2002-03-28 2002-05-08 Glaxo Group Ltd Novel compounds
GB0212355D0 (en) * 2002-05-29 2002-07-10 Glaxo Group Ltd Novel compounds
US7589199B2 (en) 2002-06-12 2009-09-15 Chemocentryx, Inc. Substituted piperazines
ES2329356T3 (es) 2002-06-12 2009-11-25 Chemocentryx, Inc. Derivados de piperazina 1-arilo-4-sustituidos utilizados como antagonistas de ccr1 para el tratamiento de enfermedades inflamatorias e inmunitarias.
US7842693B2 (en) 2002-06-12 2010-11-30 Chemocentryx, Inc. Substituted piperazines
WO2004004731A1 (en) 2002-07-02 2004-01-15 F. Hoffmann-La Roche Ag 2, 5-substituted pyrimidine derivatives as ccr-3 receptor antagonists ix
US6919356B2 (en) * 2002-09-26 2005-07-19 Bristol Myers Squibb Company N-substituted heterocyclic amines as modulators of chemokine receptor activity
ATE440835T1 (de) 2003-03-06 2009-09-15 Glaxo Group Ltd Heterozyklische harnstoff-derivate für die behandlung von schmerzen.
WO2004078744A2 (en) 2003-03-07 2004-09-16 Glaxo Group Limited Urea derivatives and their use as vanilloid receptor antagonists in the treatment of pain
GB0305426D0 (en) 2003-03-08 2003-04-16 Glaxo Group Ltd Novel compounds
EP2385040A1 (en) 2003-03-14 2011-11-09 ONO Pharmaceutical Co., Ltd. Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
US7498323B2 (en) 2003-04-18 2009-03-03 Ono Pharmaceuticals Co., Ltd. Spiro-piperidine compounds and medicinal use thereof
WO2005040129A2 (en) * 2003-10-24 2005-05-06 F. Hoffmann-La Roche Ag Ccr3 receptor antagonists
JP4845873B2 (ja) 2004-03-03 2011-12-28 ケモセントリックス インコーポレーティッド 二環式および架橋した窒素複素環
US7435831B2 (en) 2004-03-03 2008-10-14 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
RU2403237C2 (ru) * 2004-05-14 2010-11-10 Эмисфире Текнолоджис, Инк. Составы и смеси для доставки активных агентов
CA2565188C (en) * 2004-05-14 2014-03-04 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
WO2006030925A1 (ja) 2004-09-13 2006-03-23 Ono Pharmaceutical Co., Ltd. 含窒素複素環誘導体およびそれらを有効成分とする薬剤
WO2006088541A2 (en) 2005-02-17 2006-08-24 State Of Oregon Acting By & Through The State Board Of Higher Edu. On Behalf Of Portland State Unv. Quinoline derivatives and uses thereof
EP1889622A4 (en) 2005-05-31 2009-12-23 Ono Pharmaceutical Co SPIROPIPERIDINE COMPOUND AND MEDICINAL USE THEREOF
US20090118288A1 (en) * 2005-07-21 2009-05-07 Astrazeneca Ab N-Benzyl-Morpholine Derivatives as Modulators of the Chemokine Receptor
KR100743617B1 (ko) * 2005-08-25 2007-07-27 주식회사 알에스텍 고광학순도를 갖는 키랄 3-히드록시 피롤리딘 및 그유도체를 제조하는 방법
BRPI0616150A2 (pt) * 2005-09-22 2011-06-07 Sanofi Aventis derivados de amino-alquil-amida como lìquidos receptores de ccr3
HUP0500877A2 (en) * 2005-09-22 2007-05-29 Sanofi Aventis Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use and intermediates
HUP0500886A2 (en) * 2005-09-23 2007-05-29 Sanofi Aventis Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use
HUP0500879A2 (en) * 2005-09-22 2007-05-29 Sanofi Aventis Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use and intermediates
JP5251127B2 (ja) 2005-10-28 2013-07-31 小野薬品工業株式会社 塩基性基を含有する化合物およびその用途
PL1961744T3 (pl) 2005-11-18 2013-09-30 Ono Pharmaceutical Co Związek zawierający grupę zasadową oraz jego zastosowanie
US8003642B2 (en) 2006-03-10 2011-08-23 Ono Pharmaceutical Co., Ltd. Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
EP2042503B1 (en) 2006-05-16 2013-01-30 Ono Pharmaceutical Co., Ltd. Compound having acidic group which may be protected, and use thereof
EP2055705A4 (en) 2006-07-31 2014-08-20 Ono Pharmaceutical Co COMPOUND WITH A CYCLIC GROUP BOUND BY A SPIRO BINDING THEREOF AND APPLY THEREOF
WO2010129351A1 (en) 2009-04-28 2010-11-11 Schepens Eye Research Institute Method to identify and treat age-related macular degeneration
CN101906060B (zh) * 2010-05-06 2012-07-04 爱斯医药科技(南京)有限公司 N-取代的3-氨甲基吡咯烷的制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459757A (en) * 1965-10-22 1969-08-05 American Cyanamid Co Imidazolidines
NZ186175A (en) * 1977-01-27 1980-03-05 Shionogi & Co Meta-sulphonamidobenzamide derivatives
JPS59186969A (ja) * 1983-04-08 1984-10-23 Yoshitomi Pharmaceut Ind Ltd ベンゾフラン−およびベンゾピランカルボキサミド誘導体
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
JPH01117860A (ja) * 1987-10-30 1989-05-10 Dainippon Pharmaceut Co Ltd 安息香酸アミド誘導体
JPH02104572A (ja) * 1988-10-13 1990-04-17 Dainippon Pharmaceut Co Ltd 安息香酸アミド誘導体
FR2662162B1 (fr) * 1990-05-18 1995-01-20 Adir Nouveaux derives de l'amino piperidine, de l'amino pyrrolidine et de l'amino perhydroazepine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5214055A (en) * 1990-05-18 1993-05-25 Adir Et Compagnie Aminopiperidine 4-oxo-4H-chromen-2-yl compounds
US5254569A (en) * 1991-01-14 1993-10-19 The Du Pont Merck Pharmaceutical Company (Amidomethyl)nitrogen heterocyclic analgesics
GB9113031D0 (en) * 1991-06-17 1991-08-07 Smithkline Beecham Plc Compounds
FR2679906B1 (fr) * 1991-07-31 1995-01-20 Adir Nouvelles (isoquinolein-5 yl) sulfonamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO1993003725A1 (en) * 1991-08-20 1993-03-04 Smithkline Beecham Plc 5-ht4 receptor antagonists
JPH06212757A (ja) * 1993-01-19 1994-08-02 Ribaa Kentetsu Kk ソリ型運搬治具による折板屋根葺き工法
EP0742208A1 (en) * 1995-05-05 1996-11-13 Grelan Pharmaceutical Co., Ltd. 2-Ureido-benzamide derivatives
US5827875A (en) * 1996-05-10 1998-10-27 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
EP0916668A4 (en) * 1996-07-29 2000-08-16 Banyu Pharma Co Ltd CHEMOKIN RECEPTOR ANTAGONISTS
IL125658A0 (en) * 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
JPH11140276A (ja) * 1997-11-11 1999-05-25 Sumitomo Chem Co Ltd 多官能シアン酸エステル樹脂組成物および樹脂封止型半導体装置
ID24475A (id) * 1997-11-18 2000-07-20 Teijin Limeted Cs Turunan-turunan amina siklik dan penggunaannya sebagai obat

Also Published As

Publication number Publication date
ES2158814B1 (es) 2002-03-16
ITTO991009A0 (it) 1999-11-19
NO20012411D0 (no) 2001-05-16
GB2343893A (en) 2000-05-24
CN1331677A (zh) 2002-01-16
GB9927227D0 (en) 2000-01-12
EP1131288A1 (en) 2001-09-12
AR023707A1 (es) 2002-09-04
CZ20011760A3 (cs) 2001-12-12
GB2343893B (en) 2002-01-09
FR2786185A1 (fr) 2000-05-26
TR200101398T2 (tr) 2001-09-21
CA2350903A1 (en) 2000-06-02
JP3593037B2 (ja) 2004-11-24
AU763960B2 (en) 2003-08-07
AU1382500A (en) 2000-06-13
KR20010086045A (ko) 2001-09-07
CN1158256C (zh) 2004-07-21
IL143226A0 (en) 2002-04-21
NO20012411L (no) 2001-05-16
ES2158814A1 (es) 2001-09-01
PL348375A1 (en) 2002-05-20
US6166015A (en) 2000-12-26
WO2000031032A1 (en) 2000-06-02
ITTO991009A1 (it) 2001-05-19
DE19955794A1 (de) 2000-05-31
HUP0104364A2 (hu) 2002-04-29
BR9915520A (pt) 2001-07-17
MA26762A1 (fr) 2004-12-20
JP2002530374A (ja) 2002-09-17
IT1307900B1 (it) 2001-11-19
ID29067A (id) 2001-07-26
ZA200103942B (en) 2002-08-15
PE20001403A1 (es) 2000-12-15
CO5140119A1 (es) 2002-03-22

Similar Documents

Publication Publication Date Title
UY25811A1 (es) Derivados de pirrolidina que son antagonistas del receptor ccr-3
RU2327701C2 (ru) Нуклеозидные производные и фармацевтическая композиция, обладающая антивирусной активностью в отношении hcv
AR023659A1 (es) Un compuesto inhibidor de p38, una composicion farmaceutica que lo comprende y el uso de dicha composicion en el tratamiento y prevencion de estados patologicos
CO5180642A1 (es) Compuestos sustituidos de piperidina, procesos para su prepa racion, composiciones farmaceuticas que los contienen y su utilizacion
ES2093367T3 (es) Derivados de quinazolina.
UY25804A1 (es) Derivados de 4-aroilpiperidina que son antagonistas de los receptores ccr-3
ES2095960T3 (es) Compuestos que tienen propiedades antihipertensivas y antiisquemicas.
ITMI981902A0 (it) Derivati ammine cicliche che sono antagonisti di recettori ccr-3 composizioni farmaceutiche che li contengono metodi per il loro
EA200101203A1 (ru) Производные пурина
ES2078798T3 (es) Derivados de quinazolina.
AR003453A1 (es) Inhibidores de agregado de plaquetas, su uso en la fabricacion de medicamentos, composicion farmaceutica que los contiene y procedimiento para la preparacion de dichos inhibidores
AR037329A1 (es) Compuestos pirazolo pirimidinona, procedimientos para la preparacion de los mismos, composiciones farmaceuticas de los mismos y usos de los mismos en la preparacion de medicamentos
ATE158288T1 (de) Antiatherosklerotische und antithrombotische 1- benzopyran-4-on- und 2-amino-1,3-benzoxazin-4-on- derivate
KR930019637A (ko) 비페닐설포닐우레아 또는 비페닐설포닐우레탄 측쇄를 갖는 이미다졸 유도체, 이의 제조방법 및 용도
FI970317A0 (fi) Antiproliferatiivisina aineina ja Garft-inhibiittoreina käyttökelpoisia yhdisteitä
ES2128092T3 (es) Derivados de anilina.
YU21803A (sh) Farmaceutski aktivni derivati sulfonamida koji imaju i lipofilne i jonizujuće osobine kao inhibitori protein-junkinaza
AR012489A1 (es) Tiofenopiridinas antagonistas del factor de liberacion de corticotropina. procedimiento para su preparacion, el uso de las mismas en la preparacionde un medicamento, composicion farmaceutica que las comprende, procedimiento para la preparacion de dicha composicion, un compuesto intermediario y
AR024969A1 (es) Derivados de 8-fenil-6,9-dihidro-[1,2,4]triazol[3,4-i]purin-5-ona
AR016440A1 (es) Analogos tetraciclicos de camptotecina sus procedimientos de preparacion, productos intermediarios utilizados en dichos procedimientos, preparacion dedichos productos intermedios, uso de dichos analogos tetraciclicos para la preparacion de medicamentos y medicamentos y composiciones farmaceuticas qu
MEP56908A (en) Reconstitutable parenteral composition containing a cox-2 inhibitor
MX9303145A (es) 7-(2-aminoetil)benzotiazolonas.
MX9306311A (es) Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
TR200000725T2 (tr) Bir monoamin oksidaz inhibitörü ve h5-HT1B antagonistinin bileşimi
AR015446A1 (es) Antagonistas de receptores de vitronectina, composicion farmaceutica que los contiene, procedimiento para su preparacion, su uso para la elaboracion de unmedicamento y compuestos intermediarios

Legal Events

Date Code Title Description
ABAN Application deemed to be withdrawn (no publication fee paid)

Effective date: 20090416